Last updated on June 2019

Equivalence Study to Compare Two Strengths of Creon in China


Brief description of study

This will be an open-label, randomized, multicenter, cross-over study in 60 subjects with PEI delivering data of 60 subjects for Pancreatin Enteric-Coated Capsules 25000 and of 60 subjects for Pancreatin Enteric-Coated Capsules 10000. The study will be conducted in up to 10 sites in China.

Clinical Study Identifier: NCT03450772

Find a site near you

Start Over